ESMO Calls for Oncology-Specific Safeguards in the EU Critical Medicines Act By Ogkologos - June 11, 2025 855 0 Facebook Twitter Google+ Pinterest WhatsApp Ensuring equitable access to cancer treatments remains central to EU health security efforts Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR Cancer Researchers Bring Tools, Experience to COVID-19 Studies February 12, 2021 Dad Creates Inclusive Children’s Book For Daughter With Disability And Others... January 25, 2022 EMA Recommends Extension of Indications for Niraparib September 29, 2020 Combination of Immunotherapy Drugs Approved for Metastatic Colorectal Cancer August 3, 2018 Load more HOT NEWS EMA Recommends Granting a Conditional Marketing Authorisation for Selumetinib FDA Grants Accelerated Approval to Tisotumab Vedotin-tftv for Recurrent or Metastatic... Minimizing Time Between Diagnosis and End of Treatment Improves Breast Cancer... Having a Heart Attack May Make Breast Cancer Grow Faster
